Compare Kyndryl Holdings Inc (KD) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kyndryl Holdings Inc vs Nuwellis Inc — how do they compare? Kyndryl Holdings Inc trades at $11.75 (market cap $2.59B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Kyndryl Holdings Inc is far larger — about 1177.3× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 5,354,348). Which is the better fit depends on your goals — on Pluang, investors hold Kyndryl Holdings Inc for 36 Days and Nuwellis Inc for 26 Days on average.
| KD | NUWE | |
|---|---|---|
Market Cap | $2.59B | $2.20M |
Volume | 5,354,348 | 121,544 |
Sector | Technology | Health |
52-Week High | $28.92 | $146.65 |
52-Week Low | $10.59 | $0.68 |
Typical Hold Time | 36 Days | 26 Days |
Enterprise Value | $5.41B | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kyndryl Holdings (KD) trades at $11.88, up 3.76% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS beat but missed Q4 2025 and Q1 2026 expectations. Fundamentals show improving profitability with 2025 net income of $252M (1.67% margin) and strong cash flow generation of $236M. Recent news highlights AI-focused initiatives including new innovation labs and strategic acquisitions.
Outlook remains cautious with analyst consensus at Hold (71.42%) and $14.67 price target offering 23% upside. Key risks include inconsistent earnings performance, competitive pressures in IT services, and high debt levels at 30.67% debt-to-asset ratio. The stock presents potential for recovery if AI investments translate to sustained revenue growth and margin expansion.
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
